Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDialight Regulatory News (DIA)

Share Price Information for Dialight (DIA)

Share Price is delayed by 15 minutes
Get Live Data
381.00    8.00 (2.14%)
Bid:
379.00
Ask:
400.00
Spread: 21.00 (5.541%)
Market Cap: £152.30m
DIA Live PriceLast checked at - London Stock Exchange

Intraday Dialight Share Chart

Director/PDMR Shareholding

6 Apr 2022 09:58

RNS Number : 4664H
Dialight PLC
06 April 2022
 

 

 

 

Diialight plc

(the "Company")

 

Director / PDMR Shareholdings

 

 

Options under the Dialight plc Annual Performance Bonus Plan ("APBP")

On 5 April 2022, Fariyal Khanbabi, Group Chief Executive Officer and Executive Director, was granted a Deferred Share Award ("Deferred Award") in the form of nil cost options that entitled her to receive 24,327 ordinary shares of 1.89 pence each in the Company in accordance with the rules of the APBP.

 

The Deferred Award will be exercisable in two equal tranches on or after 31 January 2024 and 31 January 2025, subject to continued employment at each date of vesting.

 

No consideration was paid for the grant of these awards and no consideration is due to be paid by Fariyal Khanbabi on the vesting of the awards. A mandatory two-year post-vesting holding period applies to the award.

 

The notifications below, which have been made in accordance with the requirement of the UK Market Abuse Regulation, provide further details.

 

Richard Allan

General Counsel & Company Secretary

DD: +44 (0) 203 058 3546

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

 

1

Details of PDMR / person closely associated

 a)

Name

Fariyal Khanbabi

 2.

Reason for the notification

 a)

Position / Status

Director - Group Chief Executive Officer

 b)

Initial notification / Amendment

Initial notification

 3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 a)

Name

Dialight plc

 b)

LEI

2138001AD31KKD29Z495

 4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 1.89 pence each in Dialight plc

 

 

 

GB0033057794

 b)

 Nature of the transaction

Grant of a Deferred Share Award over 24,327 ordinary shares under the Dialight plc Annual Performance Bonus Plan

 c)

 Price (pence) and volume

Price(s)

Volume(s)

0.00

24,327

 d)

 Aggregated information

- Aggregated volume

 

- Price (pence)

 

Not applicable - single transaction

 e)

 Date of the transaction

5 April 2022

 f)

 Place of the transaction

Outside a trading venue

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUPUQACUPPURQ
Date   Source Headline
2nd Jun 20267:00 amRNSNotice of Results & Investor Presentation
28th May 20267:00 amRNSHolding(s) in Company
26th May 20267:00 amRNSHolding(s) in Company
13th May 202612:52 pmRNSHolding(s) in Company
1st May 20267:00 amRNSTotal Voting Rights and Admission of Shares
1st Apr 20269:54 amRNSTransaction in Own Shares
30th Mar 20263:43 pmRNSDirector/PDMR Shareholding
25th Mar 20269:32 amRNSDirector/PDMR Shareholding
16th Mar 202610:41 amRNSIssue of Equity and Total Voting Rights
16th Mar 202610:41 amRNSIssue of Equity and Total Voting Rights
26th Feb 20266:32 pmRNSHolding(s) in Company
8th Jan 20267:00 amRNSThird Quarter Trading Update
12th Nov 20259:33 amRNSInvestor Presentation via Investor Meet Company
11th Nov 20254:55 pmRNSDirector/PDMR Shareholding
11th Nov 20257:00 amRNSFY26 Interim Results
6th Oct 20257:00 amRNSTrading Statement
30th Sep 20257:00 amRNSBlock listing Interim Review
16th Sep 20259:39 amRNSTotal Voting Rights
3rd Sep 20251:24 pmRNSHolding(s) in Company
2nd Sep 20253:34 pmRNSResult of AGM - Addendum
1st Sep 20253:21 pmRNSResult of AGM
1st Sep 20257:00 amRNSTrading Statement
14th Aug 20251:05 pmRNSHolding(s) in Company
11th Aug 202512:58 pmRNSHolding(s) in Company
1st Aug 20255:57 pmRNSHolding(s) in Company
1st Aug 20255:54 pmRNSHolding(s) in Company
1st Aug 20255:47 pmRNSHolding(s) in Company
1st Aug 20251:33 pmRNSHolding(s) in Company
14th Jul 20252:04 pmRNSNotice of AGM
14th Jul 202510:05 amRNSAnnual Financial Report
4th Jul 20257:00 amRNSDirector/PDMR Shareholding
3rd Jul 202510:18 amRNSDirector/PDMR Shareholding
24th Jun 202512:53 pmRNSDirector/PDMR Shareholding
24th Jun 20257:00 amRNSFinal Results
1st May 20254:04 pmRNSDirectorate Change
7th Apr 20254:50 pmRNSTotal Voting Rights
7th Apr 20254:44 pmRNSBlock listing Interim Review
31st Mar 20257:00 amRNSSanmina Final Agreement, Trading update
20th Mar 20255:49 pmRNSApplication for Block Listing
20th Mar 20257:00 amRNSDirector Declaration
19th Mar 20253:37 pmRNSDirector/PDMR Shareholding
18th Mar 20255:17 pmRNSDirector/PDMR Shareholding
14th Mar 20252:42 pmRNSHolding(s) in Company
4th Feb 20257:30 amRNSDirector Declaration
4th Feb 20257:00 amRNSHolding(s) in Company
28th Jan 20257:00 amRNSTrading Statement
10th Dec 20247:00 amRNSDirectorate Change
25th Nov 20247:00 amRNSHalf-year Report
11th Nov 20247:00 amRNSDirectorate Change
4th Nov 20242:03 pmRNSDate of half-year results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.